Dova Pharmaceuticals
Charlottesville, US · Founded 2016 · Delaware corporation · 1 known investors
Publicly listed pharmaceutical company
Biotech
Founders & leadership
ER
Eugene R. ScavolaExecutive
DD
Damian deGoaExecutive
Board
RT
Russell T. SchundlerBoard director
JC
James C. ReebalsBoard director
HE
Hossein EkramiBoard director
JA
John A. StalfortBoard director
PB
Investors · 1
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2016
▶$10MraisedSep 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$10MraisedSep 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Russell T. SchundlerExecutive Officer, Promoter
- PBM Capital Investments LLCPromoter
- James C. ReebalsExecutive Officer, Promoter
- Hossein EkramiDirector
- Eugene R. ScavolaExecutive Officer, Promoter
- John A. StalfortExecutive Officer, Director, Promoter
- Damian deGoaExecutive Officer, Promoter
- BKB Growth Investments, LLCPromoter
- Paul B. ManningExecutive Officer, Director, Promoter
- Offering amount
- $40M
- Amount sold
- $10M
- Minimum investment
- $2.5M
- Proceeds to insiders
- $600K
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Dova Pharmaceuticals do?
- Publicly listed pharmaceutical company
- Who are Dova Pharmaceuticals's investors?
- Dova Pharmaceuticals's investors include PBM Capital.
- How much funding has Dova Pharmaceuticals raised?
- Dova Pharmaceuticals has disclosed $10M raised across 1 round.
- Where is Dova Pharmaceuticals headquartered?
- Dova Pharmaceuticals is headquartered in Charlottesville, US.